With NIH “Accountability” As Background, Advocates Support Budget Increases.
Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.
Bush Nominates VA Official For HHS Deputy Secretary.
Stronger Anti-Smoking Efforts Needed For Women, SG Says.
Meharry, Vanderbilt Win Grant For Research Collaboration.
FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.
US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.
Firm Begins Phase II Trial Of LDP-341 For Myeloma.
Faulding, NaPro In Agreement For Marketing Paclitaxel.
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings
